Cofoe Medical Technology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 37.22% vs -8.60% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 17.25% vs -9.31% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,012.40",
          "val2": "737.80",
          "chgp": "37.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "112.60",
          "val2": "109.70",
          "chgp": "2.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.90",
          "val2": "2.90",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.10",
          "val2": "7.30",
          "chgp": "-30.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "107.40",
          "val2": "91.60",
          "chgp": "17.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "111.30%",
          "val2": "85.50%",
          "chgp": "2.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.24% vs 4.72% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 18.57% vs 23.49% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,370.70",
          "val2": "2,976.70",
          "chgp": "13.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "528.00",
          "val2": "491.00",
          "chgp": "7.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.30",
          "val2": "20.40",
          "chgp": "-5.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "51.50",
          "val2": "12.90",
          "chgp": "299.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "370.30",
          "val2": "312.30",
          "chgp": "18.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "94.90%",
          "val2": "104.00%",
          "chgp": "-0.91%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

1,012.40

737.80

37.22%

Operating Profit (PBDIT) excl Other Income

112.60

109.70

2.64%

Interest

2.90

2.90

Exceptional Items

5.10

7.30

-30.14%

Consolidate Net Profit

107.40

91.60

17.25%

Operating Profit Margin (Excl OI)

111.30%

85.50%

2.58%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 37.22% vs -8.60% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 17.25% vs -9.31% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,370.70

2,976.70

13.24%

Operating Profit (PBDIT) excl Other Income

528.00

491.00

7.54%

Interest

19.30

20.40

-5.39%

Exceptional Items

51.50

12.90

299.22%

Consolidate Net Profit

370.30

312.30

18.57%

Operating Profit Margin (Excl OI)

94.90%

104.00%

-0.91%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 13.24% vs 4.72% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 18.57% vs 23.49% in Dec 2024

All Annual Results